Last reviewed · How we verify
C5252
At a glance
| Generic name | C5252 |
|---|---|
| Sponsor | ImmVira Pharma Co. Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C5252 CI brief — competitive landscape report
- C5252 updates RSS · CI watch RSS
- ImmVira Pharma Co. Ltd portfolio CI